4//SEC Filing
Coiante Scott M 4
Accession 0001127602-25-000084
CIK 0001062822other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:09 PM ET
Size
5.4 KB
Accession
0001127602-25-000084
Insider Transaction Report
Form 4
Coiante Scott M
SVP, Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-02+230,000→ 230,000 totalExercise: $0.74Exp: 2035-01-02→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001608536
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:09 PM ET
- Size
- 5.4 KB